WebCompany profile page for Romark Global Pharma LLC including stock price, company news, press releases, executives, board members, and contact information Skip To Content Skip … WebEmail: [email protected] VIEW OPEN POSITIONS The Application Process APPLY Start by viewing our positions. When you see a job may be a good fit, click “Apply” to start your application and upload your resume. You will receive a confirmation email once your application is submitted.
Romark Company Profile: Funding & Investors PitchBook
WebMar 15, 2016 · Romark Global Pharma has raised a total of $10.7M in funding over 1 round. This was a Debt Financing round raised on Mar 15, 2016. Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 1. Total Funding Amount $10.7M. WebApr 14, 2024 · Romark is a vertically-integrated, research-based pharmaceutical company focused on the discovery, development and delivery of innovative new medicines, … tickets msp to phx
ROMARK GLOBAL PHARMA Revenue, Growth
WebAug 20, 2024 · Romark Laboratories, L.C’s Profile, Revenue and Employees. Romark Laboratories develops and commercializes small molecules for treating infectious diseases and cancers. Romark Laboratories, L.C’s primary competitors include CoreRx, Xcelience, QOL Medical and 11 more. WebRomark is among the many companies working to respond to the novel coronavirus global health emergency. Romark has on-going clinical studies of its investigational new drug candidate NT-300 (nitazoxanide extended-release) for both the prevention and treatment of COVID-19 and other viral respiratory illnesses. See below for more information. WebDec 14, 2024 · Romark Laboratories L.C. ClinicalTrials.gov Identifier: NCT05157269 Other Study ID Numbers: RM08-3011 : First Posted: December 14, 2024 Key Record Dates: Last Update Posted: December 14, 2024 Last Verified: December 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... ticket sms twisto